Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or…
Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses 1,2 Lunsumio subcutaneous offers a new treatment option that can significantly reduce administration time to approximately one minuteAvailability of Lunsumio SC allows patients to receive treatment aligned to clinical requirements and lifestyle preferencesBasel, 19 November 2025 - Roche (SIX: RO,...
Nasdaq GlobeNewswire
19/11/2025
Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving…
Addressing the Critical Window to Save Lives Addressing the Critical Window to Save Lives Uncontrolled bleeding is the leading cause of preventable death following trauma, whether caused by accidents, mass-casualty events or in the battlefield. Caregivers need a tool which can be easily administered to a large number of casualties in a short period of time. TXA is an antifibrinolytic agent commonly used off label around the world to treat trauma bleeding in the pre-hospital and...
PR Newswire
19/11/2025
Wearable Medical Devices Market Will reach $184.75 billion by 2033 - Strategic…
This surge is also being fuelled by a fundamental shift in patient expectations. Individuals want more visibility into their own health metrics, and healthcare systems-facing workforce shortages and rising costs-need technologies that improve monitoring efficiency without compromising care quality. Against this backdrop, wearable medical devices have emerged as a cornerstone of the modern healthcare ecosystem, offering unprecedented data precision, clinical relevance, and accessibility. This...
PR Newswire
19/11/2025
New data on lecanemab to be presented at CTAD conference
Key lecanemab poster presentation: Key lecanemab poster presentation: Real-world experience: During the poster session onMonday, Dec. 1, at3:00 PM PTandTuesday, Dec. 2, at5:30 PM PT, Poster 055 presents an overview of baseline characteristics and preliminary safety findings from a study of lecanemab in Alzheimer's disease (AD) using the ALZ-NET registry. Additional lecanemab poster presentations Leqembi is the result of a long-standing collaboration between BioArctic...
PR Newswire
19/11/2025
Europe must embed patient voices to transform digestive health outcomes, urges…
"Digestive diseases affect millions of people across Europe and place significant strain on patients, families, and healthcare systems," said Professor Patrizia Burra, Chair of the UEG Public Affairs Group. "This manifesto calls for a culture of partnership – where patients' lived experiences guide research priorities, policy decisions, and clinical practice." "Digestive diseases affect millions of people acrossEuropeand place significant strain on patients, families…
PR Newswire
19/11/2025
Osteoporosis Market Set to Expand Significantly During the Forecast Period…
Osteoporosis Market Summary Osteoporosis Market Summary Discover the osteoporosis new treatment @New Treatments for Osteoporosis Key Factors Driving the Growth of the Osteoporosis Market Rising Prevalence of Osteoporosis The global burden of osteoporosis is increasing rapidly due to the growing elderly population, especially among postmenopausal women. As life expectancy rises, the prevalence of age-related bone loss and fragility fractures continues to drive the...
PR Newswire
18/11/2025
Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
About Jazz PharmaceuticalsJazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and…
PR Newswire
18/11/2025
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…
Attachment notification-of-managers-transaction-lionel-carnot-november 2025
Nasdaq GlobeNewswire
18/11/2025
Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior…
Media ReleaseCOPENHAGEN, Denmark; November 18, 2025Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that it and its wholly owned subsidiary Genmab Finance LLC (“Genmab Finance”) have priced their previously announced offering of $1.5 billion of 6.250% senior secured notes due 2032 (the “Secured Notes”) and $1.0 billion of 7.250% senior unsecured notes due 2033 (the “Unsecured Notes,” and together with the Secured Notes, the “Notes”). The issue price of the Notes is 100.000%...
Nasdaq GlobeNewswire
18/11/2025
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company AnnouncementCOPENHAGEN, Denmark; November 18, 2025 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:10,033 shares at DKK 1,025.00, 310 shares at DKK 1,147.50, 1,478 shares at DKK 1,161.00, 5,847...
Nasdaq GlobeNewswire
18/11/2025
Velico Announces Major Expansion of Manufacturing and Supply Chain Operations
The FrontlineODP™ decentralized manufacturing model envisions a global network of hundreds of blood centers, each capable of drying tens of thousands of plasma units annually. Planned adoption by leading military and civilian blood centers is accelerating across North America, Europe, and the Indo-Pacific. The combined production from installed and contracted FrontlineODP™ manufacturing systems is already expected to exceed 100,000 units per year. The FrontlineODP™ decentralized manufacturing...
PR Newswire
18/11/2025
Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and…
Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R 2 ) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the Phase 3 EPCORE ®FL-1 trial, fixed duration EPKINLY + R 2demonstrated significantly superior progression-free survival and overall response rates compared to standard of care R 2,with approximately three out of four patients achieving a complete responseThis...
Nasdaq GlobeNewswire
18/11/2025
In-vitro fertilization services in US Market to Reach $8,186.08 Million by 2027…
Request Sample of the Report on Bariatric Beds Market Forecast 2032 -https://www.alliedmarketresearch.com/request-sample/3491 Request Sample of the Report on Bariatric Beds Market Forecast 2032 -https://www.alliedmarketresearch.com/request-sample/3491 These services are widely utilized by couples facing fertility challenges due to medical, lifestyle, or age-related factors. Increasing cases of infertility, rising maternal age, delayed pregnancies, and growing awareness about...
PR Newswire
18/11/2025
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only…
— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — — BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — BRIDGEWATER, N.J., Nov. 18, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver therapies to transform the lives of patients facing serious diseases, today...
PR Newswire
18/11/2025
MiRNA Microarray Kits And Reagents Market Surges to USD 2.45 Billion by 2033…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=843532&utm_source=PRNewswire&utm_medium=360 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=843532&utm_source=PRNewswire&utm_medium=360 Browse in-depth TOC on MiRNA Microarray Kits And Reagents Market 202 - Pages 126 – Tables 37 – Figures Scope of The MiRNA Microarray Kits And Reagents Market Report Global MiRNA Microarray Kits And Reagents...
PR Newswire
18/11/2025
Animal Health Industry Poised for Explosive Growth - Forecasts Hit $112.33B by…
Download a free sample copy for more Insights on this report: Animal Health Market Download a free sample copy for more Insights on this report:Animal Health Market The growing rate of pet ownership offers an opportunity in the market. For instance, 62% of UK residents own pets. In addition, the focus on pet humanization and routine check-ups increases the adoption of animal health services. The presence of wellness products, vaccines, and surgery services helps in treating them well...
PR Newswire
18/11/2025
Metabolic Disorders Therapeutics Market Poised to Grow from US$74.97 Billion in…
Growth Outlook: A Convergence of Need and Innovation Growth Outlook: A Convergence of Need and Innovation Buy This Report with Year-End Offer ( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=metabolic-disorders-therapeutics-market Segment Insights: What is Driving Revenue? By Drug Type By Application By Route of Administration Request for Customized Sample Report as per...
PR Newswire
18/11/2025
Urology Devices Market worth US$46.26 billion by 2030 with 6.0% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212 Browse in-depth TOC on "Urology Devices Market" 312 - Tables 50 - Figures 321 - Pages By product category,the global urology devices market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the urology devices market...
PR Newswire
18/11/2025
IMed Group appoints Parminder Kalle as Chief Commercial Officer
OutspokenPR
18/11/2025
Hyland and Tribun Health partner to deliver next-generation, intelligent digital…
"This partnership between Hyland and Tribun Health positions healthcare organizations at the forefront of agentic digital pathology," said Michael Campbell, chief product officer at Hyland. "Together, we're setting a new standard for data-driven diagnostics, delivering faster, more precise diagnoses and improving patient outcomes; while reinforcing our shared commitment to driving innovation in healthcare." "This partnership between Hyland and Tribun Health positions…
PR Newswire
18/11/2025
OKYO Pharma to Present at OIS XV in San Diego
LONDON and NEW YORK, Nov.18, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, announced that Gary S. Jacob, Ph.D., Chief Executive Officer, will present at the Ophthalmology Innovation Summit (OIS) XV. The presentation is scheduled for...
Nasdaq GlobeNewswire
18/11/2025
THE ROYAL CANADIAN MINT'S OPULENCE COLLECTION RETURNS WITH PLATINUM AND GOLD…
"The Opulence Collection is a testament to the Royal Canadian Mint's dedication to innovation and coin manufacturing excellence, and the addition of rare fancy yellow diamonds creates visually stunning collector pieces that also celebrate Canada's vast mineral wealth," said Marie Lemay, President and CEO of the Royal Canadian Mint. "We are proud to once again delight collectors of fine numismatic art with rare and precious treasures produced by people and companies that are…
PR Newswire
18/11/2025
Nordic Capital to partner with Evosep, a leader in proteomics technologies for…
Nordic Capital's investment in Evosep is based on its long-standing commitment to healthcare and diagnostics with deep expertise across biopharma, medtech and diagnostic technology, including successful investments in The Binding Site, Leo Pharma, Minerva Imaging, Equashield and Clario. Nordic Capital's investment in Evosep is based on its long-standing commitment to healthcare and diagnostics with deep expertise across biopharma, medtech and diagnostic technology, including successful...
PR Newswire
18/11/2025
Proya Cosmetics Founder and Chairman Hou Juncheng Named Among "9 Faces of the…
Since its founding, Proya Cosmetics has been guided by Mr. Hou's vision of innovation-driven growth and international development. In October 2024, the company established its Europe Innovation Center, marking a major milestone in its global R&D network. Proya Cosmetics has also deepened long-term strategic partnerships with world-leading ingredient suppliers such as BASF and Ashland, further enhancing its core competitiveness. Since its founding, Proya Cosmetics has been guided by Mr...
PR Newswire
18/11/2025
Altri Comunicati
